HOME >> MEDICINE >> NEWS
Researchers discover how antibiotic inhibits bacterial growth

Researchers at the University of Illinois at Chicago, in collaboration with research teams from Pharmacia & Upjohn and Pfizer, have discovered precisely how the antibiotic linezolid inhibits bacterial growth.

Scientists have known that the drug linezolid -- the first new antibiotic to enter the marketplace in 30 years -- works by binding to ribosomes, the protein production factory of the cell. But exactly where the binding occurred and how the drug worked was not known. Until now.

"Linezolid targets ribosomes, inhibits protein synthesis, and kills bacteria," said Alexander Mankin, professor and associate director of UIC's Center for Pharmaceutical Biotechnology and lead investigator of the study. "If we know exactly where the drug binds, we can make it better and learn how to use it more effectively."

Linezolid is a synthetic antibiotic used for the treatment of infections caused by pathogens such as staph and strep, including multi-drug-resistant bacteria. Skin infections, pneumonia, and other diseases can be treated with linezolid. It is marketed in the United States as Zyvox.

Mankin and his colleagues managed not only to crosslink the drug to its target in the living cell, but to precisely characterize the mode of binding of the drug to the ribosome.

"It was a combined effort of excellent chemists, structural biologists and biochemists," Mankin said.

"We now understand much better how the drug works, how it can be improved, and how bacteria can become resistant to linezolid."

A second part of the study involved learning why, in rare cases, the drug can have side effects causing a decrease in the production of blood cells. By crosslinking linezolid to its target in human cells, the researchers showed that the drug may be toxic to mitochondria -- the power generators of the cell -- which contain ribosomes that resemble the ribosomes of bacteria.

"This is the first time such
'"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
10-May-2007


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers urge caution in using ESAs for cancer-related anemia
11. Researchers identify new therapy for patients with Crohns disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... PLEASANTON, Calif. (PRWEB) , ... July 09, 2020 ... ... (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced ... as a UroLift® Center of Excellence. The designation recognizes that Dr. Mercado has ...
(Date:7/10/2020)... ... 2020 , ... NeoTract, a wholly owned subsidiary of Teleflex ... announced that Carl Meyer, M.D., The Iowa Clinic in West Des Moines, IA, ... Dr. Meyer has achieved a high level of training and experience with the ...
(Date:7/10/2020)... (PRWEB) , ... July 10, 2020 , ... ... Release 3.0 featuring our Business Partner Vetting (BPV) Portal . Expresso® ... and upload requested documents. No more manually mailing, tracking, and performing other administrative ...
(Date:7/7/2020)... ... July 07, 2020 , ... Dr. Louis M. ... new way to improve their scalp health. It is now possible to receive Keravive ... treatment process to his practice, Dr. DeJoseph is able to provide clients with the ...
(Date:7/7/2020)... ... July 07, 2020 , ... ... two head design to efficiently sanitize large surfaces is now available in Mexico ... to support sales in that region. , In this era of worldwide pandemic, ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... Calif. (PRWEB) , ... July ... ... Review , the leading review of business and technology for the pharmaceutical ... the development and manufacturing of the highest quality pharmaceutical products. QC ...
(Date:7/7/2020)... ... July 07, 2020 , ... With projects ranging from ... the 33 nonprofits who received the latest ISA Foundation grants will ... the foundation awarded grants totaling $838,527 to the U.S.-based 501(c)(3) nonprofit organizations. ...
(Date:7/4/2020)... ... 03, 2020 , ... By Heidi Jean Doerfert , During this unprecedented time ... cover, Assuaged, Inc. is going full speed ahead. Founders Cynthia and Thane ... to get their feet wet in marketing, social media content, research, data analysis and ...
Breaking Medicine Technology:
Cached News: